epoch-f
Showing 1 - 2 of 2
Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,
Recruiting
- Myelodysplastic Syndrome
- +4 more
- Rituximab
- +6 more
-
Bethesda, Maryland
- +1 more
Aug 20, 2022
Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Disease Trial run by the NCI (Rituximab, Cyclosporine, Allogenic
Completed
- Myelodysplastic Syndrome
- +4 more
- Rituximab
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 11, 2019